The Markers That Matter: ApoB, hs-CRP, Fasting Insulin and Lp(a)

ApoB: counting the particles that matter

Cholesterol does not travel through the blood on its own. It is carried inside particles, and the particles most able to enter the artery wall and build plaque (LDL, VLDL remnants and Lp(a)) each carry exactly one molecule of apolipoprotein B. Measuring ApoB therefore gives a direct count of these harmful particles, rather than an estimate of the cholesterol inside them.

Why it can add to LDL cholesterol

Most of the time ApoB and LDL cholesterol tell the same story. They disagree most often in people with raised triglycerides, diabetes, obesity or metabolic syndrome, where each particle may carry less cholesterol, so LDL cholesterol can look reassuring while the particle count is high. The 2019 European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) guidelines recommend ApoB for risk assessment, particularly in these groups, and note it may be preferred to LDL cholesterol as a marker of risk.

What a result means

There is no single healthy number for everyone. The same guidelines set ApoB goals according to a person's overall cardiovascular risk, with lower targets for people at higher risk. A result therefore only becomes meaningful once it is placed against your age, blood pressure, smoking status, family history and other findings.

hs-CRP: a measure of low-grade inflammation

C-reactive protein (CRP) is made by the liver in response to inflammation. The high-sensitivity test, hs-CRP, measures it at the low levels that reflect persistent, low-grade inflammation rather than an acute infection. Raised levels are associated with a higher risk of heart attack and stroke, and inflammation is closely linked with metabolic disease.

How to measure it properly

These categories come from a joint American Heart Association and Centers for Disease Control and Prevention statement. Because CRP rises with any infection, injury or recent hard exercise, the statement recommends taking the average of two measurements, ideally about two weeks apart, when you are well. A result above 10 mg/L usually points to an acute infection or another inflammatory condition, and should be repeated and investigated rather than read as cardiovascular risk.

Not a diagnosis: hs-CRP is not specific to the heart. It is most useful as one piece of a wider risk assessment, and as something to track as lifestyle or treatment changes.

Fasting insulin: the early metabolic signal

Insulin resistance usually develops years before blood glucose becomes abnormal. As cells respond less well to insulin, the pancreas compensates by producing more of it, which keeps glucose in range for a time. That compensation can show up as a rising fasting insulin while fasting glucose and HbA1c still look normal.

Useful, but interpreted with care

Fasting insulin is most informative alongside fasting glucose, where the two can be combined into an estimate of insulin resistance such as HOMA-IR. It has important limits. There is no universal cut-off, and results from different laboratory methods are not fully standardised, a problem highlighted by an American Diabetes Association work group. A result is therefore best compared with your own earlier results from the same laboratory, and read together with HbA1c, waist measurement, blood pressure and lipids.

Lp(a): the inherited risk worth knowing once

Lipoprotein(a), or Lp(a), is an LDL-like particle with an extra protein attached. More than 90% of the variation in Lp(a) levels between people is genetic, so your level is largely set from early life and changes little with diet or exercise. A high level independently raises the lifetime risk of atherosclerotic cardiovascular disease and of aortic valve stenosis.

Why one test is usually enough

Because it is so stable, the 2022 European Atherosclerosis Society consensus statement recommends measuring Lp(a) at least once in every adult. Most people never have it checked, so an inherited risk can go unnoticed in families for generations.

What happens if it is high

A high Lp(a) is not a reason for alarm, but it is a reason for attention. The consensus recommends earlier and more intensive management of the risk factors that can be changed, such as blood pressure, ApoB or LDL cholesterol, smoking and blood glucose, tailored to your overall risk. It also recommends testing close relatives in certain situations, including a family history of high Lp(a) or of early cardiovascular disease.

Why a trend beats a snapshot

A single result is a snapshot. Every marker varies naturally from day to day within the same person, and every laboratory measurement carries some analytical variation. A change between two results only means something once it is larger than that combined background variation, a threshold laboratory medicine calls the reference change value.

Measured at sensible intervals, by the same laboratory where possible, a series of results reveals direction. Our August report groups what you see over time into four patterns:

• Improving: moving in the right direction, suggesting the current strategy is working.
• Stable: holding steady, suggesting the current approach is supporting balance.
• Worsening: a gradual shift that may signal rising risk before any symptom develops.
• Variable: fluctuations that may reflect inconsistent habits, stress, illness or timing of the test.

Tracking also shows whether a change you have made, in diet, training, sleep or treatment, is actually reaching your biology. That turns health decisions from assumptions into evidence.

Context is everything

No biomarker tells the full story. The same result can mean very different things for two different people, which is why interpretation depends on the whole person:

• Age: biology and baseline risk change over time.
• Body composition: muscle, fat and where fat is stored all shape metabolic risk.
• Blood pressure: a key measure of cardiovascular strain.
• Family history: inherited factors can raise baseline risk.
• Physical activity: movement supports metabolic, mental and cardiovascular health.
• Smoking status: a powerful modifier of inflammation and cardiovascular risk.
• Other laboratory findings: kidney, liver, thyroid and blood count results all add context.

The principle: no biomarker should ever be interpreted in isolation. Health is a system, and biomarkers are pieces of the puzzle. Clinical judgement brings them together into decisions that are evidence-informed, personalised and forward-looking.

Questions to take to your doctor

If you already have recent blood results, these questions help turn them into a plan:

• Has my ApoB been measured, and is it in line with my LDL cholesterol?
• Have I ever had Lp(a) checked? If not, is a once-off test appropriate for me?
• Is my hs-CRP a single reading, or an average taken while I was well?
• Do my fasting insulin and glucose together suggest early insulin resistance?
• Which of my results should we repeat, how often, and at the same laboratory?
• What is my overall cardiovascular risk once everything is taken into account?